Combing the Cancer Genome for Novel Kinase Drivers and New Therapeutic Targets

Area of Science:

• Biochemistry and Molecular Biology
• Oncology
• Genetics

Background:

• Protein kinases are key regulators of cellular processes like proliferation, growth, survival, metabolism, migration, and invasion.
• Aberrant kinase activity is linked to diseases, particularly cancer, due to dysregulated signaling pathways.
• Oncogenic kinases play a crucial role in tumor development and progression.

Purpose of the Study:

• To review the role of oncogenic kinases and their signaling pathways in cancer.
• To highlight precision medicine strategies using genomic biomarkers to target activated kinase drivers.
• To discuss progress and challenges in implementing kinase inhibitor therapies and identifying novel cancer drivers.

Main Methods:

• Literature review focusing on oncogenic kinases and cancer signaling pathways.
• Analysis of genomic biomarker-based precision medicine approaches.
• Discussion of clinical progress and future challenges in kinase-targeted cancer therapy.

Main Results:

• Oncogenic kinases are central to tumor development through regulated signaling pathways.
• Genomic biomarkers enable precision medicine by matching kinase inhibitors to specific mutations.
• Progress has been made in applying these targeted strategies in clinical settings.

Conclusions:

• Targeting oncogenic kinases with precision medicine offers a powerful strategy for cancer treatment.
• Identifying novel protein kinase cancer drivers remains a critical challenge in the genomic era.
• Combination therapies and further research are essential for advancing kinase-targeted cancer care.